Polianta Ltd Acquires New Shares in Tenet Healthcare Corporation $THC

Key Points

• Polianta Ltd. initiated a Tenet Healthcare position in the second quarter, purchasing 10,700 shares valued at approximately $2.0 million. Institutional investors collectively own 95.44% of the company.
• Tenet reported quarterly EPS of $6.12, exceeding estimates of $4.26, while revenue reached $6.04 billion and increased 6.8% year over year. The company issued fiscal 2026 EPS guidance of $20.30–$21.69.
• Analysts remain broadly bullish, with 17 Buy ratings and three Holds, producing a “Moderate Buy” consensus and an average price target of $271. Recent insider activity was negative, with insiders selling 33,953 shares worth about $7.84 million over three months.

Polianta Ltd bought a new position in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 10,700 shares of the company's stock, valued at approximately $2,001,000. Tenet Healthcare makes up approximately 0.2% of Polianta Ltd's portfolio, making the stock its 27th largest position.

A number of other hedge funds also recently modified their holdings of the business. Price T Rowe Associates Inc. MD increased its stake in Tenet Healthcare by 1.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,490,350 shares of the company's stock worth $1,488,484,000 after purchasing an additional 119,809 shares in the last quarter. Boston Partners lifted its stake in Tenet Healthcare by 15.7% in the fourth quarter. Boston Partners now owns 3,642,136 shares of the company's stock valued at $723,804,000 after buying an additional 494,581 shares in the last quarter. AQR Capital Management LLC boosted its holdings in shares of Tenet Healthcare by 20.3% in the fourth quarter. AQR Capital Management LLC now owns 2,256,539 shares of the company's stock valued at $448,419,000 after buying an additional 380,116 shares during the period. Ameriprise Financial Inc. raised its holdings in shares of Tenet Healthcare by 8.0% during the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company's stock worth $373,020,000 after acquiring an additional 157,109 shares during the period. Finally, Norges Bank acquired a new position in Tenet Healthcare in the 4th quarter worth $248,494,000. Institutional investors and hedge funds own 95.44% of the company's stock.

Tenet Healthcare Stock Performance

THC opened at $262.75 on Friday. The business's 50-day simple moving average is $200.19 and its 200 day simple moving average is $201.39. Tenet Healthcare Corporation has a 52-week low of $157.58 and a 52-week high of $265.32. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. The firm has a market capitalization of $21.16 billion, a PE ratio of 10.13, a PEG ratio of 1.00 and a beta of 1.23.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping the consensus estimate of $4.26 by $1.86. The firm had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The business's quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, sell-side analysts expect that Tenet Healthcare Corporation will post 21.09 earnings per share for the current fiscal year.

Analysts Set New Price Targets

THC has been the topic of several recent research reports. Piper Sandler set a $308.00 price target on Tenet Healthcare in a research note on Monday, July 27th. KeyCorp decreased their price objective on Tenet Healthcare from $250.00 to $225.00 and set an "overweight" rating for the company in a report on Friday, May 1st. Barclays boosted their target price on Tenet Healthcare from $240.00 to $271.00 and gave the company an "overweight" rating in a research note on Friday, July 24th. UBS Group raised their price target on shares of Tenet Healthcare from $288.00 to $308.00 and gave the stock a "buy" rating in a research note on Monday, July 27th. Finally, Royal Bank Of Canada boosted their price objective on shares of Tenet Healthcare from $236.00 to $283.00 and gave the stock an "outperform" rating in a research report on Monday, July 27th. Seventeen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, Tenet Healthcare has an average rating of "Moderate Buy" and an average price target of $271.00.

Insider Activity

In other news, EVP Lisa Y. Foo sold 10,000 shares of the company's stock in a transaction dated Wednesday, July 29th. The shares were sold at an average price of $258.03, for a total value of $2,580,300.00. Following the sale, the executive vice president directly owned 32,053 shares of the company's stock, valued at approximately $8,270,635.59. This represents a 23.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Christopher S. Lynch sold 3,837 shares of Tenet Healthcare stock in a transaction dated Monday, July 27th. The stock was sold at an average price of $243.44, for a total value of $934,079.28. Following the transaction, the director owned 9,568 shares of the company's stock, valued at $2,329,233.92. The trade was a 28.62% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 33,953 shares of company stock valued at $7,841,125. 0.97% of the stock is owned by corporate insiders.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source